Evolution of the Papillomaviridae

Virology

Volumn 445, Issue 1-2, 2013, Pages 11-20

  Van Doorslaer, Koenraad ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Co evolution; Codon usage; Evolution; Mutation rate; Niche adaptation; Papillomaviridae; Recombination

Indexed keywords

NUCLEOTIDE;

AMNIOTE; ARTICLE; BIRD; ECOLOGICAL NICHE; EVOLUTION; FAMILIA; GENE SEQUENCE; HOST; HUMAN; MAMMAL; NONHUMAN; PAPILLOMA VIRUS; PHYLOGENETIC TREE; PRIORITY JOURNAL; REPTILE; SPECIES DIFFERENTIATION; VIRUS GENOME; VIRUS ISOLATION; VIRUS TYPING;

CO-EVOLUTION; CODON USAGE; EVOLUTION; MUTATION RATE; NICHE ADAPTATION; PAPILLOMAVIRIDAE; RECOMBINATION;

ADAPTATION, BIOLOGICAL; ANIMALS; EVOLUTION, MOLECULAR; GENETIC SPECIATION; HOST-PATHOGEN INTERACTIONS; HUMANS; ONCOGENE PROTEINS, VIRAL; OPEN READING FRAMES; PAPILLOMAVIRIDAE; PHYLOGENY; REPRESSOR PROTEINS; SELECTION, GENETIC; VIRAL PROTEINS;

AMNIOTA; AVES; MAMMALIA; PAPILLOMAVIRIDAE; REPTILIA;

EID: 84884357300     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.05.012     Document Type: Article

References (100)

1. Ahola H., Stenlund A., Moreno-Lopez J., Pettersson U. Sequences of bovine papillomavirus type 1 DNA: functional and evolutionary implications. Nucleic Acids Res. 1983, 11:2639-2650.
2. Angulo M., Carvajal-Rodriguez A. Evidence of recombination within human alpha-papillomavirus. Virol. J. 2007, 4:33.
3. Astell C.R., Mol C.D., Anderson W.F. Structural and functional homology of parvovirus and papovavirus polypeptides. J. Gen. Virol. 1987, 68(Pt. 3):885-893.
4. Bernard H.U. Coevolution of papillomaviruses with human populations. Trends Microbiol. 1994, 2:140-143.
5. Bernard H.U. Taxonomy and phylogeny of papillomaviruses: an overview and recent developments. Infect. Genet. Evol. 2013.
6. Bernard H.U., Burk R.D., Chen Z., Van Doorslaer K., zur Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
7. Bernard H.U., Chan S.Y., Delius H. Evolution of papillomaviruses. Curr. Top. Microbiol. Immunol. 1994, 186:33-54.
8. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., Cogliano V. A review of human carcinogens: Part B: biological agents. Lancet Oncol. 2010, 10:321-322.
9. Bravo I.G., Alonso A. Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J. Virol. 2004, 78:13613-13626.
10. Bravo I.G., Alonso A. Phylogeny and evolution of papillomaviruses based on the E1 and E2 proteins. Virus Genes 2007, 34:249-262.
11. Bravo I.G., Muller M. Codon usage in papillomavirus genes: practical and functional aspects. Papillomavirus Rep. 2005, 16:63-72.
12. Brooks D.R. The new orthogenesis. Cladistics 2003, 19:443-448.
13. Brooks D.R., Ferrao A.L. The historical biogeography of co-evolution: emerging infectious diseases are evolutionary accidents waiting to happen. J. Biogeogr. 2005, 32:1291-1299.
14. Burk R.D., Chen Z., Van Doorslaer K. Human papillomaviruses: genetic basis of carcinogenicity. Public Health Genomics 2009, 12:281-290.
15. Carvajal-Rodriguez A. Detecting recombination and diversifying selection in human alpha-papillomavirus. Infect. Genet. Evol. 2008, 8:689-692.
16. Castoe T.A., de Koning A.P., Kim H.M., Gu W., Noonan B.P., Naylor G., Jiang Z.J., Parkinson C.L., Pollock D.D. Evidence for an ancient adaptive episode of convergent molecular evolution. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:8986-8991.
17. Chan S.Y., Bernard H.U., Ong C.K., Chan S.P., Hofmann B., Delius H. Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. J.Virol. 1992, 66:5714-5725.
18. Chan S.Y., Bernard H.U., Ratterree M., Birkebak T.A., Faras A.J., Ostrow R.S. Genomic diversity and evolution of papillomaviruses in rhesus monkeys. J.Virol. 1997, 71:4938-4943.
19. Chan S.Y., Chew S.H., Egawa K., Grussendorf-Conen E.I., Honda Y., Rubben A., Tan K.C., Bernard H.U. Phylogenetic analysis of the human papillomavirus type 2 (HPV-2), HPV-27, and HPV-57 group, which is associated with common warts. Virology 1997, 239:296-302.
20. Chan S.Y., Delius H., Halpern A.L., Bernard H.U. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J.Virol. 1995, 69:3074-3083.
21. Chen Z., Terai M., Fu L., Herrero R., DeSalle R., Burk R.D. Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J. Virol. 2005, 79:7014-7023.
22. Chen Z., van Doorslaer K., Desalle R., Wood C.E., Kaplan J.R., Wagner J.D., Burk R.D. Genomic diversity and interspecies host infection of alpha12 Macaca fascicularis papillomaviruses (MfPVs). Virology 2009, 393:304-310.
23. Chin Y.E., Kitagawa M., Su W.C., You Z.H., Iwamoto Y., Fu X.Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 1996, 272:719-722.
24. Clertant P., Seif I. A common function for polyoma virus large-T and papillomavirus E1 proteins?. Nature 1984, 311:276-279.
25. Clifford G.M., Goncalves M.A., Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006, 20:2337-2344.
26. Cole S.T., Danos O. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J. Mol. Biol. 1987, 193:599-608.
27. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
28. DeFilippis V.R., Ayala F.J., Villarreal L.P. Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes. J. Mol. Evol. 2002, 55:491-499.
29. Dobzhansky T. Nothing in biology makes sense except in the light of evolution. Am. Biol. Teach. 1973, 35:125-129.
30. Drake J.W. A constant rate of spontaneous mutation in DNA-based microbes. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:7160-7164.
31. Drummond A.J., Ho S.Y., Phillips M.J., Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS Biol. 2006, 4:e88.
32. Duffy S., Shackelton L.A., Holmes E.C. Rates of evolutionary change in viruses: patterns and determinants. Nat. Rev. Genet. 2008, 9:267-276.
33. Ellis J.R., Keating P.J., Baird J., Hounsell E.F., Renouf D.V., Rowe M., Hopkins D., Duggan-Keen M.F., Bartholomew J.S., Young L.S., et al. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1995, 1:464-470.
34. Firth A.E., Brown C.M. Detecting overlapping coding sequences in virus genomes. BMC Bioinformatics 2006, 7:75.
35. Fu L., Van Doorslaer K., Chen Z., Ristriani T., Masson M., Trave G., Burk R.D. Degradation of p53 by human Alphapapillomavirus E6 proteins shows a stronger correlation with phylogeny than oncogenicity. PLoS One 2010, 5:e12816.
36. Garcia-Vallve S., Alonso A., Bravo I.G. Papillomaviruses: different genes have different histories. Trends Microbiol. 2005, 13:514-521.
37. Gottschling M., Bravo I.G., Schulz E., Bracho M.A., Deaville R., Jepson P.D., Van Bressem M.F., Stockfleth E., Nindl I. Modular organizations of novel cetacean papillomaviruses. Mol. Phylogenet. Evol. 2011, 59:34-42.
38. Gottschling M., Goker M., Stamatakis A., Bininda-Emonds O.R., Nindl I., Bravo I.G. Quantifying the phylodynamic forces driving papillomavirus evolution. Mol. Biol. Evol. 2011, 28:2101-2113.
39. Gottschling M., Kohler A., Stockfleth E., Nindl I. Phylogenetic analysis of beta-papillomaviruses as inferred from nucleotide and amino acid sequence data. Mol. Phylogenet. Evol. 2007, 42:213-222.
40. Gottschling M., Stamatakis A., Nindl I., Stockfleth E., Alonso A., Bravo I.G. Multiple evolutionary mechanisms drive papillomavirus diversification. Mol. Biol. Evol. 2007, 24:1242-1258.
41. Gouy M., Gautier C. Codon usage in bacteria: correlation with gene expressivity. Nucleic Acids Res. 1982, 10:7055-7074.
42. Guindon S., Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 2003, 52:696-704.
43. Hafner M.S., Nadler S.A. Phylogenetic trees support the coevolution of parasites and their hosts. Nature 1988, 332:258-259.
44. Halpern A.L. Assessing recombination in HPV, Part I. Human Papillomaviruses 1995, 1995. Los Alamos National Laboratory, Los Alamos, NM. G. Myers, C.C. Baker, K. Munger, F. Sverdrup, A.A. McBride, H.U. Bernard (Eds.).
45. Hiller T., Poppelreuther S., Stubenrauch F., Iftner T. Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidemiologic risk classification. Cancer Epidemiol. Biomarkers Prev. 2006, 15:1262-1267.
46. Hiller T., Stubenrauch F., Iftner T. Isolation and functional analysis of five HPVE6 variants with respect to p53 degradation. J. Med. Virol. 2008, 80:478-483.
47. Holmes E.C. Viral evolution in the genomic age. PLoS Biol. 2007, 5:e278.
48. Hu J., Cladel N.M., Budgeon L., Balogh K.K., Christensen N.D. Papillomavirus DNA complementation in vivo. Virus Res. 2009, 144:117-122.
49. Jiang M., Xi L.F., Edelstein Z.R., Galloway D.A., Olsem G.J., Lin W.C., Kiviat N.B. Identification of recombinant human papillomavirus type 16 variants. Virology 2009, 394:8-11.
50. Kaasila M., Koskela P., Kirnbauer R., Pukkala E., Surcel H.M., Lehtinen M. Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile-aged Finnish women. Int. J. Cancer 2009, 125:2166-2172.
51. Kimura M. Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature 1977, 267:275-276.
52. Klingelhutz A.J., Roman A. Cellular transformation by human papillomaviruses: Lessons learned by comparing high- and low-risk viruses. Virology 2012, 424:77-98.
53. Kumar S., Subramanian S. Mutation rates in mammalian genomes. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:803-808.
54. Liu X., Clements A., Zhao K., Marmorstein R. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor. J. Biol. Chem. 2006, 281:578-586.
55. Lynch M. Evolution of the mutation rate. Trends Genet. 2010, 26:345-352.
56. Moore P.S., Chang Y. Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. Trends Genet. 1998, 14:144-150.
57. Moore P.S., Chang Y. Kaposi's sarcoma-associated herpesvirus immunoevasion and tumorigenesis: two sides of the same coin?. Annu. Rev. Microbiol. 2003, 57:609-639.
58. Moore P.S., Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 2010, 10:878-889.
59. Moriyama E.N., Powell J.R. Codon usage bias and tRNA abundance in Drosophila. J. Mol. Evol. 1997, 45:514-523.
60. Muench P., Hiller T., Probst S., Florea A.M., Stubenrauch F., Iftner T. Binding of PDZ proteins to HPV E6 proteins does neither correlate with epidemiological risk classification nor with the immortalization of foreskin keratinocytes. Virology 2009, 387:380-387.
61. Narechania A., Chen Z., DeSalle R., Burk R.D. Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses. J.Virol. 2005, 79:15503-15510.
62. Narechania A., Terai M., Burk R.D. Overlapping reading frames in closely related human papillomaviruses result in modular rates of selection within E2. J. Gen. Virol. 2005, 86:1307-1313.
63. O'Brien V., Grindlay G.J., Campo M.S. Cell transformation by the E5/E8 protein of bovine papillomavirus type 4. p27(Kip1), elevated through increased protein synthesis is sequestered by cyclin D1-CDK4 complexes. J. Biol. Chem. 2001, 276:33861-33868.
64. Ohlenschlager O., Seiboth T., Zengerling H., Briese L., Marchanka A., Ramachandran R., Baum M., Korbas M., Meyer-Klaucke W., Durst M., Gorlach M. Solution structure of the partially folded high-risk human papilloma virus 45 oncoprotein E7. Oncogene 2006, 25:5953-5959.
65. Ong C.K., Chan S.Y., Campo M.S., Fujinaga K., Mavromara-Nazos P., Labropoulou V., Pfister H., Tay S.K., ter Meulen J., Villa L.L., Bernard H.U. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J. Virol. 1993, 67:6424-6431.
66. Orlando P.A., Gatenby R.A., Giuliano A.R., Brown J.S. Evolutionary ecology of human papillomavirus: trade-offs, coexistence, and origins of high-risk and low-risk types. J. Infect. Dis. 2012, 205:272-279.
67. Page R.D.M. Tangled Trees: Phylogeny, Cospeciation, and Coevolution 2002, University Of Chicago Press. 1st ed.
68. Plummer M., Schiffman M., Castle P.E., Maucort-Boulch D., Wheeler C.M. A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis. 2007, 195:1582-1589.
69. Powell J.R., Moriyama E.N. Evolution of codon usage bias in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:7784-7790.
70. Rebrikov D.V., Bulina M.E., Bogdanova E.A., Vagner L.L., Lukyanov S.A. Complete genome sequence of a novel extrachromosomal virus-like element identified in planarian Girardia tigrina. BMC Genomics 2002, 3:15.
71. Rector A., Lemey P., Tachezy R., Mostmans S., Ghim S.J., Van D.K., Roelke M., Bush M., Montali R.J., Joslin J., Burk R.D., Jenson A.B., Sundberg J.P., Shapiro B., Van R.M. Ancient papillomavirus-host co-speciation in Felidae. Genome Biol. 2007, 8:R57.
72. Rector A., Stevens H., Lacave G., Lemey P., Mostmans S., Salbany A., Vos M., Van Doorslaer K., Ghim S.J., Rehtanz M., Bossart G.D., Jenson A.B., Van Ranst M. Genomic characterization of novel dolphin papillomaviruses provides indications for recombination within the Papillomaviridae. Virology 2008, 378:151-161.
73. Rector, A., Van Ranst, M. Animal papillomaviruses. Virology, http://dx.doi.org/10.1016/j.virol.2013.05.007, in press.
74. Rector A., Tachezy R., Van Ranst M. A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification. J. Virol. 2004, 78:4993-4998.
75. Rozenblatt-Rosen O., Deo R.C., Padi M., Adelmant G., Calderwood M.A., Rolland T., Grace M., Dricot A., Askenazi M., Tavares M., Pevzner S.J., Abderazzaq F., Byrdsong D., Carvunis A.R., Chen A.A., Cheng J., Correll M., Duarte M., Fan C., Feltkamp M.C., Ficarro S.B., Franchi R., Garg B.K., Gulbahce N., Hao T., Holthaus A.M., James R., Korkhin A., Litovchick L., Mar J.C., Pak T.R., Rabello S., Rubio R., Shen Y., Singh S., Spangle J.M., Tasan M., Wanamaker S., Webber J.T., Roecklein-Canfield J., Johannsen E., Barabasi A.L., Beroukhim R., Kieff E., Cusick M.E., Hill D.E., Munger K., Marto J.A., Quackenbush J., Roth F.P., DeCaprio J.A., Vidal M. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. Nature 2012, 487:491-495.
76. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907.
77. Schiffman M., Clifford G., Buonaguro F.M. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect. Agent Cancer 2009, 4:8.
78. Schiffman M., Rodriguez A.C., Chen Z., Wacholder S., Herrero R., Hildesheim A., Desalle R., Befano B., Yu K., Safaeian M., Sherman M.E., Morales J., Guillen D., Alfaro M., Hutchinson M., Solomon D., Castle P.E., Burk R.D. A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia. Cancer Res. 2010, 70:3159-3169.
79. Shackelton L.A., Parrish C.R., Holmes E.C. Evolutionary basis of codon usage and nucleotide composition bias in vertebrate DNA viruses. J. Mol. Evol. 2006, 62:551-563.
80. Shadan F.F., Villarreal L.P. The evolution of small DNA viruses of eukaryotes: past and present considerations. Virus Genes 1995, 11:239-257.
81. Shah S.D., Doorbar J., Goldstein R.A. Analysis of host-parasite incongruence in papillomavirus evolution using importance sampling. Mol. Biol. Evol. 2010, 27:1301-1314.
82. Sharp P.M., Stenico M., Peden J.F., Lloyd A.T. Codon usage: mutational bias, translational selection, or both?. Biochem. Soc. Trans. 1993, 21:835-841.
83. Sharp P.M., Tuohy T.M., Mosurski K.R. Codon usage in yeast: cluster analysis clearly differentiates highly and lowly expressed genes. Nucleic Acids Res. 1986, 14:5125-5143.
84. Smith B., Chen Z., Reimers L., van Doorslaer K., Schiffman M., Desalle R., Herrero R., Yu K., Wacholder S., Wang T., Burk R.D. Sequence imputation of HPV16 genomes for genetic association studies. PLoS One 2011, 6:e21375.
85. Stanley M., Lowy D.R., Frazer I. Chapter 12: prophylactic HPV vaccines: underlying mechanisms. Vaccine 2006, 24(3):S3/106-113.
86. Sundberg J.P., Van Ranst M., Burk R.D., Jenson A.B., von Krogh G., Gross G. The Nonhuman (Animal) Papillomaviruses: Host Range, Epitope Conservation, and Molecular Diversity, Human Papillomavirus Infections in Dermatovenereology 1997, 47-68. CRC Press, Boca Raton.
87. Takaoka A., Hayakawa S., Yanai H., Stoiber D., Negishi H., Kikuchi H., Sasaki S., Imai K., Shibue T., Honda K., Taniguchi T. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 2003, 424:516-523.
88. Van Doorslaer K., Burk R.D. Evolution of human papillomavirus carcinogenicity. Adv. Virus Res. 2010, 77:41-62.
89. Van Doorslaer K., Burk R.D. Association between hTERT activation by HPV E6 proteins and oncogenic risk. Virology 2012, 433:216-219.
90. Van Doorslaer K., Sidi A.O., Zanier K., Rybin V., Deryckere F., Rector A., Burk R.D., Lienau E.K., van Ranst M., Trave G. Identification of unusual E6 and E7 proteins within avian papillomaviruses: cellular localization, biophysical characterization, and phylogenetic analysis. J. Virol. 2009, 83:8759-8770.
91. Van Doorslaer K., Tan Q., Xirasagar S., Bandaru S., Gopalan V., Mohamoud Y., Huyen Y., McBride A.A. The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res. 2013, 41:D571-D578.
92. Varsani A., van der Walt E., Heath L., Rybicki E.P., Williamson A.L., Martin D.P. Evidence of ancient papillomavirus recombination. J. Gen. Virol. 2006, 87:2527-2531.
93. Vartanian J.P., Guetard D., Henry M., Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 2008, 320:230-233.
94. White E.A., Howley P.M. Proteomic approaches to the study of papillomavirus-host interactions. Virology 2013, 435:57-69.
95. White E.A., Kramer R.E., Tan M.J., Hayes S.D., Harper J.W., Howley P.M. Comprehensive analysis of host cellular interactions with human papillomavirus E6 proteins identifies new E6 binding partners and reflects viral diversity. J. Virol. 2012, 86:13174-13186.
96. White E.A., Sowa M.E., Tan M.J., Jeudy S., Hayes S.D., Santha S., Munger K., Harper J.W., Howley P.M. Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E260-E267.
97. Woolford L., Rector A., Van Ranst M., Ducki A., Bennett M.D., Nicholls P.K., Warren K.S., Swan R.A., Wilcox G.E., O'Hara A.J. A novel virus detected in papillomas and carcinomas of the endangered western barred bandicoot (Perameles bougainville) exhibits genomic features of both the Papillomaviridae and Polyomaviridae. J. Virol. 2007, 81:13280-13290.
98. Yang Z., Bielawski J.P. Statistical methods for detecting molecular adaptation. Trends Ecol. Evol. 2000, 15:496-503.
99. Zanier K., Charbonnier S., Sidi A.O., McEwen A.G., Ferrario M.G., Poussin-Courmontagne P., Cura V., Brimer N., Babah K.O., Ansari T., Muller I., Stote R.H., Cavarelli J., Vande Pol S., Trave G. Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins. Science 2013, 339:694-698.
100. Zhou J., Liu W.J., Peng S.W., Sun X.Y., Frazer I. Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J. Virol. 1999, 73:4972-4982.